The Same Deviation Again? Dig Deeper
Source: Outsourced Pharma
This segment of the Outsourced Pharma Live event, “Your CDMO Quality Oversight Is Not Working,” explores why recurring deviations can expose weaknesses in both a CDMO’s investigations and a sponsor’s oversight. Andrea and Greg discuss why repeated findings of human error deserve scrutiny, how limited resources and insufficient cross-functional input weaken root cause analysis, and when sponsors need to take a more active role in driving effective corrective and preventive actions. Featuring Andrea Goddard, CTO, CatalYm GmbH, and Greg Whitehead, EVP/CTO, Editas Medicine.
Access The Video!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.
Subscribe to Outsourced Pharma
X
Subscribe to Outsourced Pharma